TY - JOUR T1 - On the anti-correlation between COVID-19 infection rate and natural UV light in the UK JF - medRxiv DO - 10.1101/2020.11.28.20240242 SP - 2020.11.28.20240242 AU - Arnon Blum AU - Constantina Nicolaou AU - Ben Henghes AU - Ofer Lahav Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/30/2020.11.28.20240242.abstract N2 - While it is well established that the rate of COVID-19 infections can be suppressed by social distancing, environmental effects may also affect the infection rate. Here we consider the hypothesis that natural Ultra-Violet (UV) light (UVA and UVB) is reducing COVID-19 infections by enhancing human immunity through vitamin-D and/or by suppressing the virus itself. We focus on the United Kingdom (UK), by examining daily COVID-19 infections (F) and UV Index (UVI) data over the period March to October 2020. We find an intriguing empirical anti-correlation between log10(F) and log10(UVI) with a correlation coefficient of -0.933 over the period from 11 May (when the first UK lockdown ended) to 28 October 2020. The anticorrelation may reflect causation with other factors which are correlated with the UVI. Either way, UVI should be included in modelling the pattern of COVID-19 infections and deaths. We started quantifying such correlations in other countries and regions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBH, OL and CN are supported by the STFC UCL Centre for Doctoral Training in Data Intensive Science (grant number ST/P006736/1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe use publicly available data from JHU on COVID-19 and from TEMIS on UVI. ER -